Members Trust’s Bristol-Myers Squibb BMY Stock Holding History

Members Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,368	Closed	-$215K	–	106
2023 Q2	$215K	Buy	+3,368	New	+$226K	0.01%	107
2022 Q4	–	Sell	-3,540	Closed	-$252K	–	47
2022 Q3	$252K	Sell	3,540 -100	-3%	-$7.25K	0.01%	92
2022 Q2	$280K	Sell	3,640 -445	-11%	-$33.9K	0.01%	84
2022 Q1	$298K	Sell	4,085 -590	-13%	-$39.6K	0.01%	91
2021 Q4	$291K	Sell	4,675 -889	-16%	-$52.1K	0.01%	98
2021 Q3	$337K	Buy	5,564 +710	+15%	+$46.8K	0.01%	92
2021 Q2	$324K	Sell	4,854 -1,385	-22%	-$90.3K	0.01%	93
2021 Q1	$394K	Sell	6,239 -1,412	-18%	-$87.9K	0.01%	78
2020 Q4	$475K	Buy	7,651 +938	+14%	+$57.7K	0.02%	69
2020 Q3	$405K	Buy	6,713 +2,141	+47%	+$129K	0.02%	67
2020 Q2	$269K	Buy	+4,572	New	+$273K	0.01%	83
2016 Q3	–	Sell	-3,039	Closed	-$223K	–	90
2016 Q2	$223K	Buy	+3,039	New	+$215K	0.01%	80

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Members Trust's BMY Position: Q3 2023 in Review

Members Trust sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,368 shares — an estimated $215K sold.

Members Trust first reported a position in BMY in Q2 2016 and held it in 12 quarters. The position peaked at $475K in Q4 2020. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Members Trust reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Members Trust sold 3,368 Bristol-Myers Squibb shares in Q3 2023, an estimated $215K.
Members Trust first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 12 quarters.
Members Trust's Bristol-Myers Squibb position peaked at $475K in Q4 2020.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Members Trust's 13F filing for Q3 2023, filed 6 Oct 2023.